SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
-----------------------------
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
-----------------------------
Date of Report (Date of earliest event reported): February 28, 2003
Quest Diagnostics Incorporated
(Exact name of Registrant as specified in its charter)
Delaware 1-12215 16-1387862
(State or other jurisdiction Commission File Number (I.R.S. Employer
of incorporation) Identification Number)
-----------------------------
One Malcolm Avenue
Teterboro, New Jersey 07608
(201) 393-5000
(Address of principal executive offices and telephone number,
including area code)
-----------------------------
Item 9. Regulation FD Disclosure.
------------------------
On February 27, 2003, Kenneth W. Freeman, the Chief Executive Officer of Quest
Diagnostics Incorporated, and Robert A. Hagemann, the Chief Financial Officer of
Quest Diagnostics Incorporated, submitted to the Securities and Exchange
Commission sworn statements pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
Signature
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
Dated: February 28, 2003
QUEST DIAGNOSTICS INCORPORATED
By: /s/Leo C. Farrenkopf, Jr.
-----------------------------------------
Name: Leo C. Farrenkopf, Jr.
Title: Vice President and Secretary
Exhibit Index
Exhibit 99.1 Statement Pursuant to 18. U.S.C. 'SS' 1350 of Chief Executive
Officer dated February 27, 2003
Exhibit 99.2 Statement Pursuant to 18. U.S.C. 'SS' 1350 of Chief Financial
Officer dated February 27, 2003
STATEMENT OF DIFFERENCES
------------------------
The section symbol shall be expressed as..................................'SS'